Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

Glioblastoma (GBM) is an incurable brain tumor for which new treatment strategies are urgently needed. Next‐generation sequencing of GBM has most often been performed retrospectively and on archival tissue from both diagnostic and relapse surgeries with limited knowledge of clinical information, inc...

Descripción completa

Detalles Bibliográficos

Autores principales:	Dorte S. Nørøxe, Christina W. Yde, Olga Østrup, Signe R. Michaelsen, Ane Y. Schmidt, Savvas Kinalis, Mathias H. Torp, Jane Skjøth‐Rasmussen, Jannick Brennum, Petra Hamerlik, Hans S. Poulsen, Finn C. Nielsen, Ulrik Lassen
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2020-11-01
Colección:	Molecular Oncology
Materias:	chromosomal instability genomic profiling newly diagnosed glioblastoma NTRK fusion translational relevance tumor mutational burden
Acceso en línea:	https://doi.org/10.1002/1878-0261.12790
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!